Clik here to view.
Clik here to view.
Investment Bridge Announces Investment Opinion: Bridge Report on R-Tech Ueno...
TOKYO Investment Bridge, one of Japan’s leading independent IR services companies, has released a “Bridge Report” on R-Tech Ueno, Ltd. (JASDAQ:4573) reviewing the results for the first half and...
View ArticleClik here to view.
BioTime, Inc. Subsidiary OncoCyte Corporation Initiates Clinical Development...
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OncoCyte Corporation today announced that OncoCyte has initiated clinical development of its bladder cancer diagnostic test in both...
View ArticleClik here to view.
The Belmont® Rapid Infuser Expands Distribution to Japan
BILLERICA, Mass. Belmont Instrument Corporation announced this week that the Belmont® Rapid Infuser has been approved for use in Japan and will begin distributing the device through its partnership...
View ArticleClik here to view.
Covidien Receives Japanese Regulatory Approval for Reinforced Stapling Reload...
DUBLIN, Ireland Covidien plc (NYSE: COV) today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare for...
View ArticleClik here to view.
Quantum Biosystems Demonstrates First Reads Using Quantum Single Molecule...
OSAKA, Japan Quantum Biosystems today announced the release of raw data access to its first reads. The company released reads showing an accuracy of more than 99% in non-homopolymer regions and...
View ArticleClik here to view.
Quantum Biosystems展示采用单分子测序技术的首批读数
日本大阪 (美国商业资讯)–Quantum Biosystems今天公布了其首批读数的原始数据。该公司发布的读数显示，非均聚物区域的准确率超过99%，均聚物插入缺失区准确率约为10%。此次发布使研究人员能够评估该平台，并参与该平台的验证和开发。它标志着DNA的单分子电子测序领域的一次重大里程碑。 无需试剂的硅测序仪有望实现极低成本 Quantum...
View ArticleClik here to view.
Clik here to view.
阿斯利康、DKFZ和EORTC加入WIN联合会
巴黎 (美国商业资讯)–世界个体化抗癌医学创新网络联合会（简称WIN联合会）自豪地宣布，阿斯利康、DKFZ和EORTC已加入联合会。WIN是由领先的学术机构、企业、支付方和患者权益组织构成的独特全球网络，旨在为世界各地患者实现精准抗癌治疗。WIN创始人兼首席运营官Vladimir...
View ArticleClik here to view.
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia
CAMBRIDGE, Mass. & MELBOURNE, Australia ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and Specialised Therapeutics Australia Pty Ltd (STA), a specialty pharmaceutical company, today announced that...
View ArticleClik here to view.
LifeCell Corporation收购先进的脂肪组织注射器
圣安东尼奥 Kinetic Concepts, Inc. (KCI)今天宣布，LifeCell Corporation (LifeCell) 从总部位于加州门洛帕克的医疗器械孵化商TauTona...
View ArticleClik here to view.
Clik here to view.
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and...
CAMBRIDGE, Mass. & BRUSSELS, Belgium Biogen Idec (NASDAQ: BIIB) and UCB (Euronext: UCB) announced today that they have signed exclusive agreements granting UCB the right to commercialize Biogen...
View ArticleClik here to view.
Hoya Announces Third Quarter Financial Results Under IFRS
TOKYO Hoya Corporation (TOKYO:7741) today announced financial results for the third quarter ended December 31, 2013. The full reports are available at: http://www.hoya.com/investor/ During the...
View ArticleClik here to view.
Sosei Signs Distribution Agreement with FUJIFILM Pharma for Commercialization...
TOKYO Sosei Group Corporation (TOKYO:4565), the biopharmaceutical company, today announces that its Japanese subsidiary, Sosei Co., Ltd., (“Sosei K.K.”) has signed a distribution agreement for...
View ArticleClik here to view.
ArQule Announces Commencement of Phase 3 Clinical Trial with Tivantinib in...
WOBURN, Mass. ArQule, Inc. (Nasdaq: ARQL) today reported the announcement by its partner, Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151) of the initiation of a Phase 3 clinical trial evaluating...
View ArticleClik here to view.
Verastem社のmTORC1/2及びPI3K低分子二重阻害薬VS-5584に日本の特許が承認される
米国マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — がん幹細胞を標的とした抗癌剤の開発を行っている Verastem 社（NASDAQ; VSTM）は、日本の特許庁から同社の mTORC1/2 及び PI3K 低分子二重阻害薬であるVS-5584に特許が付与された事を本日公表した。当該特許は「キナーゼ阻害剤としてのピリミジン置換プリン化合物 」 ( Pyrimidine...
View ArticleClik here to view.
Clik here to view.
Mitsui Chemicals Announces World’s First Large Scale XDI Plant
Smart Multimedia Gallery Mitsui Chemicals is the world top share opthalmic lens monomers supplier (Photo: Business Wire) View and Share Photo Download Small TOKYO Mitsui Chemicals...
View ArticleClik here to view.
BSD Medical Announces Taiwan Food and Drug Administration Marketing and...
SALT LAKE CITY BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that...
View Article